First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Florence Raynaud Debashis Sarker Paul A Clarke Richard Baird Víctor Moreno Mark R. Lackner |
| Publication date | January 1, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |